The prognostic impact of the pathological response to neoadjuvant dose-dense therapy for ovarian carcinoma. (February 2017) - Takahiro, E.; Yunokawa, M.; Yoshida, H.; Bun, S.; Shimoi, T.; Shimomura, A.; Noguchi, E.; Kodaira, M.; Yonemori, K.; Shimizu, C.; Fujiwara, Y.; Kato, T.; et al.